A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate equivalent safety and IOP-lowering effectiveness
of two Travoprost/Timolol combination products in patients diagnosed with open-angle glaucoma
or ocular hypertension. This global study will be conducted in the US (C-07-64, NCT00672997)
and Japan (C-08-08, NCT00760539).